From Carotid plaque biology to serologic markers of vulnerability to predict the risk of cerebrovascular events

Acta Chirurgica Belgica

Volumn 107, Issue 2, 2007, Pages 129-142

  Cola, C ^a   Clementi, F ^a   Biondi Zoccai, G ^b   Sangiorgi, G ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c EMO GVM CENTRO CUORE COLUMBUS   (Italy)

Author keywords

Atherosclerotic plaque; Biomarkers; Carotid artery disease; Serology; Stroke

Indexed keywords

EID: 34248327212     PISSN: 00015458     EISSN: 25770160     Source Type: Journal    
DOI: 10.1080/00015458.2007.11680029     Document Type: Article

References (102)

1. GIBBS R. J., TODD J. C., IRVINE C., LAWRENSON R., NEWSON R., GREENHALGH R. M., DAVIES A. H. Relationship between the regional and national incidence of transient ischemic attack and stroke and performance of carotid endarterectomy. Eur J Vasc Surg, 1998, 16 : 47-52.
2. RINGELSTEIN E. B., SIEVERS C., ECKER S., SCHNEIDER P. A., OTIS S. M. Noninvasive assessment of CO2-induced cerebral vasomotor response in normal individuals and patients with internal carotid artery occlusion. Stroke, 1988, 19 : 963-969.
3. NASCET. North American Symptomatic Carotid Endarterectomy Trial (NASCET). Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med, 1991, 325 : 445-453.
4. ECST. Randomised trial of endarterectomy for recently symptomatic carotid stenosis : final results of the MRC European Carotid Surgery Trial. Lancet, 1998, 351 : 1379-1387.
5. ACAS. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA, 1995, 273 : 1421-1428.
6. MARKUS H. S., THOMSON N. D., BROWN M. M. Asymptomatic cerebral embolie signals in symptomatic and asymptomatic carotid artery disease. Brain, 1995, 118 (Part 4) : 1005-1011.
7. GOLLEDGE J., GREENHALGH R. M., DAVIES A. H. The symptomatic carotid plaque. Stroke, 2000, 31 : 774-781.
8. ROSS R. Atherosclerosis : an inflammatory disease. N Engl J Med, 1999, 340: 115-126.
9. VIRMANI R., BURKE A. P., FARB A. H., KOLODGIE F. D. Pathology of the unstable plaque. Prog Cardiovasc Dis, 2002, 44 : 349-356.
10. SEEGER J. M., BARRATT E., LAWSON G. A., KLINOMAN N. The relationship between carotid plaque composition, plaque morphology and neurologic symptoms. J Surg Res, 1995, 58 : 330-336.
11. BASSIOUNY H. S., SAKAGUCHI Y., MIKUCKI S. A., MCKINSEY J. F., PIANO G., GEWERTZ B. L., GLAGOV S. Juxtalumen location of plaques necrosis and neoformation in symptomatic carotid stenosis. J Vasc Surg, 1997, 26 : 585-594.
12. HATSUKAMI T. S., FERGUSON M.S., BEACH K. W., GORDON D., DETMER P., BURNS D., ALPERS C., STRANDNESS D. E. J. Carotid plaque morphology and clinical events. Stroke, 1997, 28: 95-100.
13. ARROYO L. H., LEE R. T. Mechanism of plaque rupture : mechanical and biologic interactions. Cardiovasc Res, 1999, 41 : 369-375.
14. DIRKSEN M. T., VAN DER WAL A. C., VAN DER BERG F. M., VAN DER LOOS C. M., BECKER A. E. Distribution of inflammatory cells in atherosclerotic plaques relates to the direction of flow. Circulation, 1998, 98 : 200-203.
15. SHAH P. K., FALK E., BADIMON J. J., FERNANDEZ-ORTIZ A., MAILHAC A., VILLAREAL- LEVY G., FALLON J., REGNSTROM J., FUSTER V. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation, 1995, 92 : 1565-1569.
16. GALIS Z. S., MUSZYNSKI M., SUKHOVA G. K., SIMON-MORRISSEY E., UNEMORI E. N., LARK M. W., AMENTO E., LIBBY P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res, 1994, 75: 181-189.
17. SPAGNOLI L. G., BONANNO E., MAURIELLO A., PALMIERI G., PARTENZI A., CREA F. Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction. J Am Coll Cardiol, 2002 : 1579-1588.
18. BEST P., HASDAI D., SANGIORGI G., SCHWARTZ R. S., D.R.JR. H., SIMARI R. D., LERMAN A. Apoptosis : basic concepts and implications in coronary artery disease. Arterioscler Thromb Vasc Biol, 1999, 19: 14-22.
19. DE MICHELE M., ASCIONE L., GUARINI P., PERROTTA S., TUCCILLO B. Determinanti dell'instabilità della placca carotidea : dall'istologia agli ultrasuoni. Ital Heart J Suppl, 2001, 2 : 606-613.
20. JANDER S., SITZER M., SCHUMANN R., SCHROETER M., SIEBLER M., STEINMETZ H., STOLL G. Inflammation in high-grade carotid stenosis. A possible role for macrophages and T cells in plaque destabilization. Stroke, 1998, 29 : 1625-1630.
21. SITZER M., MULLER W., SIEBLER M., HORT W., KNIEMEYER H. W., JANKE L., STEINMETZ H. Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. Stroke, 1995, 26 : 1231-1233.
22. FUKUMOTO Y., LIBBY P., RABKIN E., HILL C. C., ENOMOTO M., HIROUCHI Y., SHIOMI M., AIKAVA M. Statins alter smooth uscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits. Circulation, 2001, 103: 993-999.
23. SPAGNOLI L. G., MAURIELLO A., SANGIORGI G., FRATONI S., BONANNO E., SCHWARTZ R. S., PIEPGRAS D. G., PISTOLESE R., IPPOLITI A., HOLMES D. R. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA, 2004, 292 : 1845-1852.
24. CARR S., FARB A., PEARCE W. H., VIRMANI R., YAO J. S. Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg, 1996, 23 : 755-766.
25. REDGRAVE J. N., LOVETT J. K., GALLAGHER P. J., ROTHWELL P. M. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms : the Oxford plaque study. Circulation, 2006, 113 : 2320-2328.
26. BASSIOUNY H. S., DAVIS H., MASSAWA N., GEWERTZ B. L., GLAGOV S., ZARINS C. K. Critical carotid stenoses : morphologic and chemical similarity between symptomatic and asymptomatic plaques. J Vasc Surg, 1989, 9 : 202-212.
27. BARNETT H. J., MELDRUM H. E., ELIASZIW M. The dilemma of surgical treatment for patients with asymptomatic carotid disease. Ann Intern Med, 1995, 123 : 723-725.
28. GRAY-WEALE A. C., GRAHAM J. C., BURNETT J. R., BYRNE K., LUSBY R. J. Carotid artery atheroma : comparison of preoperative Bmode ultrasound appearance with carotid endarterectomy specimen pathology. J Cardiovasc Surg, 1988, 29: 676-681.
29. ALY S., BISHOP C. C. An objective characterization of atherosclerotic lesion. An alternative method to identify unstable plaque. Stroke, 2000, 31 : 1921-1924.
30. LAL B. K., HOBSON R. W., PAPPAS P. J., KUBICKA R., HAMEED M., CHAKHTOURA E. Y., JAMIL Z., PADBERG F. T. J., HASER B. P., DURAN W. N. Pixel distribution analysis of B-mode ultrasound scan images predicts histologic features of atherosclerotic carotid plaque. J Vasc Surg, 2002, 35 : 1210-1217.
31. BREZINSKI M. E., TEARNEY G. J., BOUMA B. E., IZATT J. A., HEE M. R., SWANSON E. A., SOUTHERN J. F., FUJIMOTO J. G. Optical coherence tomography for optical biopsy. Properties and demonstration of vascular pathology. Circulation, 1996, 93 : 1206-1213.
32. CESPEDES E. I., DE KORTE C. L., VAN DER STEEN A. F., VON BIRGELEN C., LANCEE C. T. Intravascular elastography : principles and potentials. Semin Interv Cardiol, 1997, 2 : 55-62.
33. HELFT G., WORTHLEY S. G., BEYGUI F., ZAMAN A. G., LE FEUVRE C., VACHERON A., METZQUER J. P., BADIMON J. J., FUSTER V. Identification of unstable coronary atherosclerotic plaques. Arch Mal Coeur Vaiss, 2001, 94 : 583-590.
34. ROMER T. J., BRENNAN J. F., PUPPELS G. J., ZWINDERMAN A. H., VAN DUINEN S. G., VAN DER LAARSE A., VAN DER STEEN A. F., BOM N. A., BRUSCHKE A. V. Intravascular ultrasound combined with Raman spectroscopy to localize and quantify cholesterol and calcium salts in atherosclerotic coronary arteries. Arterioscler Thromb Vasc Biol, 2000, 20 : 478-483.
35. SHINNAR M., FALLON J. T., WEHRLI S., LEVIN M., DALMACY D., FAYAD Z. A., BADIMON J. J., HARRINGTON M., HARRINGTON E., FUSTER V. The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. Arterioscler Thromb Vasc Biol, 1999, 19 : 2756-2761.
36. CASSCELLS W., HATHORN B., DAVID M., KRABACH T., VAUGHN W. K., MCALLISTER H. A., BEARMAN G., WILLERSON J. T. Thermal detection of cellular infiltrates in living atherosclerotic plaques : possible implication for plaque rupture and thrombosis. Lancet, 1996, 347 : 1447-1451.
37. STEFANADIS C., DIAMANTOPOULOS L., VLACHOPOULOS C., TSIAMIS E., DERNELLIS J., TOUTOUZAS K., STEFANADI E., TOUTOUZAS P. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo : a new method of detection by application of a special thermography catheter. Circulation, 1999, 99 : 1965-1971.
38. COSTANTINIDES P. Pathogenesis of cerebral artery thrombosis in man. Arch Pathol, 1967, 83 : 422-428.
39. FAYAD Z. A., FUSTER V. Clinical imaging of the high-risk of vulnerable atherosclertic plaque. Circ Res., 2001, 89 : 305-316.
40. STEFANIDIS C., TOUTOUZAS K., TSIAMIS E. et al Thermal etherogeneity in stable human coronary atherosclerotic plaques is undersestimated in vivo : the "cooling effect" of blood flow. J Am Coll Cardiol, 2003, 41 : 403-408.
41. RUEHM S. G., COROT C., VOGT P., KOLB S., DEBATIN J. F. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation, Jan 23, 2001, 103 (3) : 415-422.
42. LEDERMAN R. J., RAYLMANN R. R., FISHER S. J. et al. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglugose (FDG). Nucl Med Commun, 2001, 22 : 747-753.
43. CIAVOLELLA M., TAVOLARO R., TAURINO M., DI LORETO M., GRECO C., SBARIGIA E., CASINI A., SPEZIALE F., SCOPINARO F. Immunoscintigraphy of atherosclerotic uncomplicated lesions in vivo with a monoclonal antibody against D-dimers of insoluble fibrin. Atherosclerosis, Mar 1999, 143 : 171-175.
44. SCHMITZ S. A., COUPLAND S. E., GUST R., WINTERHALTER S., WAGNER S., KRESSE M., SEMMLER W., WOLF K. J. Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. Invest Radiol, Aug 2000, 35 (8) : 460-471.
45. SCHMITZ S. A., TAUPITZ M., WAGNER S., COUPLAND S. E., GUST R., NIKOLOVA A., WOLF K. J. Iron-oxide-enhanced magnetic resonance imaging of atherosclerotic plaques : postmortem analysis of accuracy, inter-observer agreement, and pitfalls. Invest Radiol, Jul, 2002, 37 : 405-411.
46. YUAN C., KERWIN W. S., FERGUSON M. S., POLISSAR N., ZHANG S., CAI J., HATSUKAMI T. S. Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging, Jan, 2002, 15 : 62-67.
47. BLAKE G. J., RIDKER P. M. Inflammatory mechanisms in atherosclerosis : from laboratory evidence to clinical application. Ital Heart J Suppl, 2001, 2 : 796-800.
48. RIDKER P.M., RIFAI N., ROSE L., BURING J. E., COOK N. R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med, 2002, 347 : 1557-1565.
49. RIDKER P., STAMPFER M., RIFAI N. Novel risk factors for systemic atherosclerosis : a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA, 2001, 285 : 2481-2485.
50. FORD E., GILES W. Serum C-reactive protein and self-reported stroke : findings from the Third National Health and Nutrition Examination Survey. Arterioscler Thromb Vasc Biol, 2000, 20 : 1052-1056.
51. GUSSELKLOO J., SCHAAP M., FROEHLICH M., BLAUW G., WESTENDORP R. C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons. Arterioscler Thromb Vasc Biol, 2000, 20 : 1047-1051.
52. CAO J., THACH C., MANOLIO T. P. B. M., KULLER L., CHAVES P., POLAR J., SUTTON- TYRELL K., HERRINGTON D., PRICE T., CUSHMAN M. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly. Circulation, 2003, 108: 166-170.
53. SCHILLINGER M., EXNER M., MLEKUSCH W., SABETI S., AMIGHI J. N., TIMMEL E., KICKINGER B., MINAR C., PONES M., LALOUSCHEK W., RUMPOLD H., MAURER G., WAGNER O. M. Inflammation and Carotid Artery-Risk for Atherosclerosis Study (ICARAS). Circulation, 2005, 111 : 2203-2209.
54. KOLODGIE F. D., GOLD H. K., BURKE A. P., FOWLER D. R., KRUTH H. S., WEBER D. K., FARB A., GUERRERO L. J., HAYASE M., KUTYS R., NARULA J., FINN A. V., VIRMANI R. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med, 2003, 349: 2285-2282.
55. NAGHAVI M., LIBBY P., FALK E., CASSCELLS S. W., LITOVSKY S., RUMBERGER J., BADIMON J. J., STEFANADIS C., MORENO P., PASTERKAMP et al. From vulnerable plaque to vulnerable patient : a call for new definitions and risk assessment strategies : part I. Circulation, 2003, 108 : 1664-1672.
56. BURKE A. P., FARB A., MALCOM G. T., LIANG Y. H., SMIALEK J., VIRMANI R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med, 1997, 336: 1276-1282.
57. BUFFON A., BIASUCCI L. M., LIUZZO G., D'ONOFRIO G., CREA F., MASERI A. Widespread cronary inflammation in unstable angina. A N Engl J Med, 2002, 347 : 5-12.
58. GOLDSTEIN J. A., DEMETRIOU D., GRINES C. L., PICA M., SHOUKJEH M., O'NEILL W. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med, 2000, 343 : 915-922.
59. ALVAREZ GARCIA B., RUIZ C., CHACON P., SABIN J. M. High-sensitivity C-reactive protein in high-grade carotid stenosis : risk marker for unstable carotid plaque. J Vasc Surg, 2003, 38 : 1018-1024.
60. BAYES-GENIS A., CONOVER C. A., OVERGAARD M. T., BAILEY K. R., CHRISTIANSEN M., HOMES D. R. J., VIRMANI R., OXVIG C., SCHWARTZ R. S. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med, 2001, 345 : 1022-1029.
61. OXVIG C., SAND O., KRISTENSEN T., KRISTENSEN L., SOTTRUPJENSEN L. Isolation and characterization of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein. Biochim Biophys Acta, 1994, 1201 : 415-423.
62. LAURSEN L. S., OVERGAARD M. T., SOE R. Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF : implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett, 2001, 504 : 36-40.
63. BAYES-GENIS A., CONOVER C. A., SCHWARTZ R. S. The insulinlike growth factor axis. A review of atherosclerosis and restenosis. Circ Res, 2000, 86 : 125-130.
64. O'BRIEN K. D., MCDONALD T. O., CHAIT A. A., ALLEN M. D., ALPERS C. E. Neovasculature expression of E-selectin, intracellular adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation, 1996, 93 : 672-682.
65. RANIER G., CLEMENT I., DESFAITS A. C., LAMBERT A. Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alpha production. Endocrinology, 1996, 137 : 4611-4618.
66. LIBBY P., AIKAWA M. Mechanisms of plaque stabilization with statins. Am J Cardiol (Suppl), 2003, 91 : 4B-8B.
67. HEESCHEN C., DIMMELER S., HAMM C. W., FICHTLSCHERER S., SIMOONS M. L., ZEIHER A. M. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes : comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol, 2005, 45 : 229-237.
68. ELESBER A., CONOVER C., DENKTAS A. E., LENNON R. J., HOLMES D. R., LERMAN A., OVERGAARD M., CHRISTIANSEN M., OXVIG C., LERMAN A. Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. European Heart Journal, 2006, 27 : 1678-1684.
69. COSIN-SALES J., CHRISTIANSEN M., KAMINSKI P., OXVIG C., OVERGAARD M., COLE D. Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation, 2004, 109 : 1724-1728.
70. BEAUDEUX J. L., BURC L., IMBERT-B ISMUT F., GIRAL P., BERNARD M., BRUCKERT E. Serum plasma pregnancy-associated protein A : a potential marker of echogenic carotid atherosclerotic plaques in asymptomatic hyperlipidemic subjects at high cardiovascular risk. Arterioscler Thromb Vasc Biol, 2003, 23 : 7-10.
71. SANGIOROI G., MAURIELLO A., BONANNO E., OXVIG C., CONOVER C. A., CHRISTIANSEN M., TRIMARCHI S., RAMPOLDI V., HOLMES D. R., JR., SCHWARTZ R. S., SPAGNOLI L. G. Pregnancy-associated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques : a link between inflammation and cerebrovascular events. J Am Coll Cardiol, 2006, 47 : 2201-2211.
72. DAVIES M. J., GORDON J. L., GEARING A. J., PIGOTT R., WOOLF N., KATZ D., KYRIAKOPOULOS A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol, 1993, 171 : 223-229.
73. RIDKER P. M., RIFAI N., STAMPFER M. J., HENNEKENS C. H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction in apparently healthy men. Circulation, 2000, 101 : 1767-1772.
74. PETER K., NAWROTH P., CONRADT C., NORDT T., WEISS T., BOEHME M., WUNSCH A., ALLENBERG J., KUBLER W., BODE C. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol, 1997, 17 : 505-512.
75. LIBBY P., AIKAWA M. New insights into plaque stabilisation by lipid lowering. Drugs, 1998, 56 : 9-13.
76. MALLAT Z., CORBAZ A., SCOAZEC A., BESNARD S., LESECHE G., CHVATCHKO Y., TEDGUI A. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation, 2001, 104 : 1598-1603.
77. MALLAT Z., NAKAMURA T., OHAN J., G. L., TEDQUI A., MACLOUF J., MURPHY RC. The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis. J Clin Invest, 1999, 103 : 421-427.
78. LIUZZO G., KOPECKY S. L., FRYE R. L., O' FALLON W. M., MASERI A., GORONZY J. J., WEYAND C. M. Perturbation of Tcell repertoire in patients with unstable angina. Circulation, 1999, 100:2135-2139.
79. EHARA S., UEDA M., NARUKO T., HAZE K., ITOH A., OTSUKA M., KOMATSU R., MATSUO T., ITABE H., TAKANO T., TSUKAMOTO Y., YOSHIYAMA M., TAKEUCHI K., YOSHIKAWA J., BECKER A. E. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation, 2001, 103 : 1955-1960.
80. TSIMIKAS S., BRILAKIS E. S., MILLER E. R., MCCONNELL J. P., LENNON R. J., KORNMAN K. S., WITZTUM J. L., BERGER P. B. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med, 2005, 353 : 46-57.
81. TOSHIMA S., HASEGAWA A., K-URABAYASHI M., ITABE H., TAKANO T., SUGANO J., SHIMAMURA K., KIMURA J., MICHISHITA I., SUZUKI T., NAGAI R. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol, 2000, 20 : 2243-2247.
82. HOLVOET P., HARRIS T. B., TRACY R. P., VERHAMME P., NEWMAN A. B., RUBIN S. M., SIMONSICK E. M., COLBERT L. H., KRITCHEVSKY S. B. Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly : findings from the Health, Aging, and Body Composition study. Arterioscler Thromb Vasc Biol, 2003, 23 : 1444-1448.
83. HOLVOET P., KRITCHEVSKY S. B., TRACY R. P., MERTENS A., RUBIN S. M., BUTLER J., GOODPASTER B., HARRIS T. B. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes, 2004, 53 : 1068-1073.
84. WALLENFELDT K., FAGERBERG B., WIKSTRAND J., HULTHE J. Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men. J Intern Med, 2004, 256 : 413-420.
85. RHOADS G. G., DAHLEN G., BERG K., MORTON N. E., DANNENBERG A. L. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA, 1986, 256 : 2540-2544.
86. DANESH J., COLLINS R., PETO R. Lipoprotein(a) and coronary artery disease. Meta-analysis of prospective studies. Circulation, 2000, 102 : 1082-1085.
87. EDELSTEIN C., ITALIA J. A., SCANU A. M. Polymorphonuclear cells isolated from human peripheral blood cleave lipoprotein(a) and apolipoprotein(a) at multiple interkringle sites via the enzyme elastase. Generation of mini-Lp(a) particles and apo(a) fragments. J Biol Chem, 1997, 272 : 11079-11087.
88. FORTUNATO J. E., BASSIOUNY H. S., SONG R. H., KOCHARIAN H., GLAGOV S., EDELSTEIN C., SCANU A. M. Apolipoprotein(a) fragments in relation to human carotid plaque instability. J Vasc Surg, 2000, 32 : 555-563.
89. OEI H. H., VAN DER MEER I. M., HOFMAN A., KOUDSTAAL P. J., STIJNEN T., BRETELER M. M., WITTEMAN J. C. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke : the Rotterdam Study. Circulation, 2005, 111 : 570-575.
90. MACPHEE C. H., MOORES K. E., BOYD H. F., DHANAK D., IFE R. J., LEACH C. A. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein : use of a novel inhibitor. Biochem J, 1999, 338 : 479-487.
91. SUDHIR K. Lipoprotein-associated phospholipase A2, a novel inflammatory biomarker and independent risk predictor for cardiovascular disease. J Clin Endocrinol Metab, 2005, 90 : 3100-3105.
92. PACKARD C. J., O'REILLY D. S., CASLAKE M. J., MCMAHON A. D., FORD I., COONEY J., MACPHEE C. H., SUCKLING K. E., KRISHNA M., WILKINSON F. E., RUMLEY A., LOWE G. D. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med, 2000, 343 : 1148-1155.
93. KOENIG W., KHUSEYINOVA N., LOWEL H., TRISCHLER G., MEISINGER C. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general popula tion : results from the 14-year follow-up of a large cohort from southern Germany. Circulation, 2004, 110 : 1903-1908.
94. COOKE J. P. FLOW, NO, and atherogenesis. Proc Natl Acad Sci U S A., 2003, 100 : 768-770.
95. ZEIHER A. M. Endothelial vasodilator dysfunction : pathogenetic link to myocardial ischaemia or epiphenomenon? Lancet, Nov, 1996, 348 Suppl 1 : s10-12.
96. COOKE J. P. Asymmetrical dimethylarginine : the Uber marker? Circulation, 2004, 109 : 1813-1818.
97. SCHACHINGER V., BRITTEN M. B., ZEIHER A. M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation, 2000, 101: 1899-1906.
98. ASAHARA T., MUROHARA T., SULLIVAN A., SILVER M., VAN DER ZEE R., LI T., WITZENBICHLER B., SCHATTEMAN G., ISNER J. M. Isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997, 275 : 964-967.
99. HILL J. M., ZALOS G., HALCOX J. P., SCHENKE W. H., WACLAWIW M. A., QUYYUMI A. A., FINKEL T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med, 2003, 348 : 593-600.
100. HAZEN S. L., HEINECKE J. W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest Radiol, 1997, 99 : 2075-2081.
101. PODREZ E. A., FEBBRAIO M., SHEIBANI N., SCHMITT D., SILVERSTEIN R. L., HAJJAR D. P., COHEN P. A., FRAZIER W. A., HOFF H. F., HAZEN S. L. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J Clin Invest, 2000, 105 : 1095-1108.
102. HAZEN S. L. Myeloperoxidase and plaque vulnerability. Arterioscler Thromb Vasc Biol, 2004, 24 : 1143-1146.